References
- Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European J Cancer 2013;49:1374-1403.10.1016/j.ejca.2012.12.027
- Citrin D, Mansueti J, Likhacheva A, Sciuto L, Albert PS, Rudy SF, et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiation Oncology Biol Phys 2009;74:1040-1046.10.1016/j.ijrobp.2008.09.053
- Cartmill B, Cornwell P, Ward E, Davidson W, Porceddu S. Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1-T3 oropharyngeal cancer. Support Care Cancer 2012;20:2073-2081.2208120610.1007/s00520-011-1316-4
- Chera BS, Eisbruch A, Murphy BA, et al. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. J Natl Cancer Inst 2014;106:1-4.
- Citak E, Tulek Z. Longitudinal quality of life in Turkish patients with head and neck cancer undergoing radiotherapy. Support Care Cancer 2013;21:2171-2183.2347519510.1007/s00520-013-1774-y
- Lee LY, Chen SC, Chen WC, Huang BS, Lin CY. Post radiation trismus and its impact on quality of life in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:187-195.10.1016/j.oooo.2014.10.003
- Reeve BB, Cai J, Zhang H, Weissler MC, Wisniewski K, Gross H, et al. Factors that impact health-related quality of life over time for individuals with head and neck cancer. Laryngoscope 2016;126:2718-2725.2722402410.1002/lary.26073
- Rigoni L, Bruhn RF, De Cicco R, Kanda JL, Matos LL. Quality of life impairment in patients with head and neck cancer and their caregivers: a comparative study. Braz J Otorhinolaryngol. 2016;82:680-686.10.1016/j.bjorl.2015.12.01227133907
- Hsieh LC, Chen JW, Wang LY, Tsang YM, Shueng PW, Liao LJ, et al. Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging. PLOS ONE2014;9:e92561, 1-8.10.1371/journal.pone.009256124658376
- Van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CRN, et al. Dysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiotherapy and Oncology 2013;106:364-369.10.1016/j.radonc.2013.03.005
- Gebre-Medhin M, Haghanegi M, Robert L, Kjellen E, Nilsson P. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncologica 2016;55:1313-1317.10.1080/0284186X.2016.1221129
- Wetzels J-W GH, Merkx MAW, de HaanAJ, Koole R, Speksnijder CM. Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective study. Head & Neck 2014;36:1754-1762.2447821710.1002/hed.23534
- Steiner F, Evans J, Marsh P, Rigby P, James S, Sutherland K, et al. Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer. Int J Oral Maxillofac Surg 2015;44:292-296.2557766410.1016/j.ijom.2014.12.009
- Rodrigues A, Kondo C A, Procópio AS, Gualberto J. Helkimo and craniomandibular indices in the classification of temporomandibular disorders. A Comparative Study. MYOPAIN 2016;1:1-6.
- Dijkstra PU, Huisman PM, Roodenburg JLN. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35:337-342.10.1016/j.ijom.2005.08.00116280237
- Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 1989;18:176-171.
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.10.1093/jnci/85.5.3658433390
- Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ –C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 2000;36:1796-1807.10.1016/S0959-8049(00)00186-610974628
- Singer S, Araujo C, ArrarasJI, Baumann I, Boehm A, Brokstad Herlofson B, et al. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N module, Phase III. Head & Neck 2015;37:1358-1367.10.1002/hed.2376224832623
- Oken MM, Creech RH, Tormey DC, Horton J. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.10.1097/00000421-198212000-000147165009
- Mezitis M, Rallis G, Zachariades N. The normal range of mouth opening. J Oral Maxillofac Surg 1989;47:1028-1029.10.1016/0278-2391(89)90174-22795295
- Gallagher C, Gallagher V, Whelon H, Cronin M. The normal range of mouth opening in an Irish population. J Oral Rehab 2004;31:110-116.10.1046/j.0305-182X.2003.01209.x
- Khare N, Patil SB, Kale SM, Sumeet J, Sonali I, Sumeet B. Normal mouth opening in an adult Indian population. J Maxillofac Oral Surg 2012;11:309-313.10.1007/s12663-012-0334-1
- Nicolatou-Galitis O, Sarri T, Dardoufas K, Kouloulias V, Sotiropoulou-Lontou A, Vakalsi X, et al. Oral mucositis, pain and xerostomia in patients with head and neck cancer who received chemoradiotherapy with or without cetuximab. The Open Clinical Cancer J 2010;4:6-14.10.2174/1874189401004010006
- Nicolatou-Galitis O, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Athanassiadou P, et al. Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy. The Open Cancer J 2011;4:7-17.10.2174/1874079001104010007
- Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010;18:1039-1060.2023780510.1007/s00520-010-0827-8
- Loorents V, Rosell J, Salgado H, Borjeson S. Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC). SpringerPlus 2016; 10.1186/s40064-016-2295-1.27347463
- Pauli N, Johnson J, Finizia K, Andrell P. The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer. Acta Oncologica 2013;52:1137-1145.10.3109/0284186X.2012.744466
- Van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CRN, Hilgers FJM. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemotherapy: Feasibility, compliance, and short-term effects. Dysphagia 2011;26:155-170.2062330510.1007/s00455-010-9288-y
- Pauli N, Fagerberg-Mohlin B, AndrellP, Finizia C. Exercise intervention for the treatment of trismus in head and neck cancer. Acta Oncologica 2014;53:502-509.10.3109/0284186X.2013.837583
- Loorents V, Rossel J, Karlsson C, Lidback M, Hultman K, Borjeson S. Prophylactic training for the prevention of radiotherapy-induced trismus - a randomized study. Acta Odontologica 2014;53:530-538.
- Kamstra JI, Reintsema H, Roodenburg JLN, Dijkstra PU. Dynasplint trismus system exercises for trismus secondary to head and neck cancer: a prospective explorative study. Support Care Cancer 2016;24:3315-3323.2695671310.1007/s00520-016-3131-4
- Func CS, Warmling CM, Baldisserotto J. A randomized clinical trial to evaluate the impact of a dental care program in the quality of life of head and neck cancer patients. Clin Oral Invest 2013. 10.1007/s00784-013-1068-2.